Hyderabad, July 30 -- Agilent Technologies, a global leader in life sciences and diagnostics, has inaugurated a new Biopharma Capability Center in Hyderabad, marking a major step in its expansion strategy for India over the next three to five years.

This facility is aimed at enhancing India's role in global biopharma innovation and drug development.

The center was launched by Telangana's IT and Industries Minister Duddila Sridhar Babu, alongside Agilent's global CEO Padraig McDonnell.

Equipped with advanced lab technologies, training modules, and regulatory-ready workflows, the center is designed to support the full drug development lifecycle, especially in biologics, biosimilars, and precision medicine.

Offering end-to-end solutions ...